Funded entirely by taxpayer dollars, this first-of-its-kind drug targets cellular metabolism to promote tissue repair of multiple organs.

Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin—a ...

Regulatory T cells, which prevent the immune system from attacking the body, were the subject of this year’s Physiology or ...

Massload Technologies, Canada’s only VCAP-certified load cell manufacturer, is significantly expanding its engineering services across strategic USA markets, bringing four decades of specialized ...